From GlobeNewswire: 2025-06-20 20:16:00

Enzon Pharmaceuticals, Inc. and Viskase Companies, Inc. have agreed to merge in an all-stock transaction. The combined company will operate as Viskase Holdings, Inc. with Timothy P. Feast as CEO. Shareholders of Viskase will receive Enzon Common Stock as part of the merger. The transaction is subject to regulatory approvals and shareholder votes. Enzon is a public company acquisition vehicle, while Viskase produces casings for meat products and operates globally. Additional details can be found in the Registration Statement to be filed with the SEC. For more information, visit Enzon’s website or the SEC’s website.



Read more at GlobeNewswire: Enzon and Viskase Enter into Merger Agreement